These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21137565)

  • 1. [Biphosphonate treatment can cause stress fracture. But treatment benefits significantly overweight the risk].
    Sjödén G; Sayed-Noor A; Kadum B; Pettersson U
    Lakartidningen; 2010 Oct 13-19; 107(41):2482-3. PubMed ID: 21137565
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical femoral fractures bilaterally in a patient receiving denosumab.
    Drampalos E; Skarpas G; Barbounakis N; Michos I
    Acta Orthop; 2014 Feb; 85(1):3-5. PubMed ID: 24171686
    [No Abstract]   [Full Text] [Related]  

  • 3. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?
    Kwek EB; Goh SK; Koh JS; Png MA; Howe TS
    Injury; 2008 Feb; 39(2):224-31. PubMed ID: 18222447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histology of an undisplaced femoral fatigue fracture in association with bisphosphonate treatment. Frozen bone with remodelling at the crack.
    Aspenberg P; Schilcher J; Fahlgren A
    Acta Orthop; 2010 Aug; 81(4):460-2. PubMed ID: 20515438
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical fracture of the femur in a patient using denosumab--a case report.
    Schilcher J; Aspenberg P
    Acta Orthop; 2014 Feb; 85(1):6-7. PubMed ID: 24460109
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures--a case report.
    Puah KL; Tan MH
    Acta Orthop; 2011 Jun; 82(3):380-2. PubMed ID: 21561306
    [No Abstract]   [Full Text] [Related]  

  • 7. Alendronate-associated femoral insufficiency fractures and femoral stress reactions.
    Wang K; Moaveni A; Dowrick A; Liew S
    J Orthop Surg (Hong Kong); 2011 Apr; 19(1):89-92. PubMed ID: 21519086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.
    Selga J; Nuñez JH; Minguell J; Lalanza M; Garrido M
    Osteoporos Int; 2016 Feb; 27(2):827-32. PubMed ID: 26501556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case reports: two femoral insufficiency fractures after long-term alendronate therapy.
    Sayed-Noor AS; Sjödén GO
    Clin Orthop Relat Res; 2009 Jul; 467(7):1921-6. PubMed ID: 19198962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alendronate-related femoral diaphysis fracture--what should be done to predict and prevent subsequent fracture of the contralateral side?
    Edwards MH; McCrae FC; Young-Min SA
    Osteoporos Int; 2010 Apr; 21(4):701-3. PubMed ID: 19562241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous bilateral atypical femoral fractures after alendronate therapy.
    Zafeiris CP; Stathopoulos IP; Kourkoumelis G; Gkikas E; Lyritis GP
    J Musculoskelet Neuronal Interact; 2012 Dec; 12(4):262-4. PubMed ID: 23196269
    [No Abstract]   [Full Text] [Related]  

  • 12. Femoral canal obliteration secondary to prolonged alendronate use: a case report.
    Lim CT; Setiobudi T; Das De S
    J Orthop Surg (Hong Kong); 2012 Apr; 20(1):115-7. PubMed ID: 22535826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral ulna fractures associated with bisphosphonate therapy.
    Ang BF; Koh JS; Ng AC; Howe TS
    Osteoporos Int; 2013 Apr; 24(4):1523-5. PubMed ID: 22903294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis.
    Chiu WY; Lee JJ; Tsai KS
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E723-6. PubMed ID: 23471975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rational approach to management of alendronate-related subtrochanteric fractures.
    Das De S; Setiobudi T; Shen L; Das De S
    J Bone Joint Surg Br; 2010 May; 92(5):679-86. PubMed ID: 20436006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
    Cross MB; Nam D; van der Meulen MC; Bostrom MP
    J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.
    Bamrungsong T; Pongchaiyakul C
    J Med Assoc Thai; 2010 May; 93(5):620-4. PubMed ID: 20524451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical femoral fracture after long-term alendronate treatment: report of a case evidenced with magnetic resonance imaging.
    Kao CM; Huang PJ; Chen CH; Chen SJ; Cheng YM
    Kaohsiung J Med Sci; 2012 Oct; 28(10):555-8. PubMed ID: 23089322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy.
    Atik OS; Suluova F; Görmeli G; Yildirim A; Ali AKh
    Eklem Hastalik Cerrahisi; 2010 Apr; 21(1):56-9. PubMed ID: 20302562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diaphyseal femoral fatigue fracture associated with bisphosphonate therapy - 3 more cases.
    Osugi K; Miwa S; Marukawa S; Marukawa K; Kawaguchi Y; Nakato S
    Acta Orthop; 2011 Feb; 82(1):112-3. PubMed ID: 21142824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.